TEVA logo

TEVA Capital Expenditure

Latest reported-$550.00M
TEVA TTM CapEx (-$134.07M → -$550.00M)
High-resolution chart · PNG

TEVA capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-550,000,000
-542,000,000
-501,000,000
-488,000,000
-500,000,000
-501,000,000
-498,000,000
-488,000,000
-489,000,000
-511,000,000
-526,000,000
-549,000,000
-522,000,000
-530,000,000
-548,000,000
-559,000,000
-583,000,000
-569,000,000
-562,000,000
-585,000,000
-582,000,000
-600,000,000
-578,000,000
-521,000,000
-547,000,000
-528,000,000
-525,000,000
-619,000,000
-589,000,000
-613,000,000
-651,000,000
-705,000,000
-778,000,000
-835,000,000
-874,000,000
-940,000,000
-949,000,000
-931,000,000
-901,000,000
-816,000,000
-765,000,000
-759,000,000
-772,000,000
-824,000,000
-866,000,000
-889,000,000
-929,000,000
-943,000,000
-959,000,000
-992,000,000
-1,031,000,000
-1,044,000,000
-1,065,000,000
-1,094,000,000
-1,104,000,000
-1,094,000,000
-1,121,000,000
-1,093,000,000
-1,053,000,000
-970,000,000
-869,000,000
-779,000,000
-710,000,000
-846,000,000
-867,000,000
-882,000,000
-877,000,000
-688,000,000
-670,000,000
-699,000,000
-681,000,000
-648,000,000
-598,000,000
-528,000,000
-542,000,000
-511,900,000
-481,600,000
-473,600,000
-390,000,000
-355,400,000
-340,800,000
-305,200,000
-310,100,000
-326,200,000
-318,100,000
-324,200,000
-311,000,000
-276,600,000
-259,500,000
-234,700,000
-207,500,000
-193,000,000
-167,700,000
-168,300,000
-160,400,000
-152,966,000
-151,646,000
-139,683,000
-134,066,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.